NCT02320877View on ClinicalTrials.gov

Evaluation of the Cardiovascular Effects of the MAS in the Treatment of Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
OSA
Interventions
DEVICE

Mandibular Advancement Device (Somnomed Flex)

The SomnoDent Flex™ MAS is a custom-made, titratable MAS that is validated in randomized controlled trials described in literature

Trial Locations (1)

2650

Antwerp University Hospital, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER

NCT02320877 - Evaluation of the Cardiovascular Effects of the MAS in the Treatment of Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter